Focal therapy for prostate cancer has evolved over 2 decades, with advances in imaging, patient selection, treatment modalities, and clinical trials.
Kara L. Watts, MD
Advertisement
Kara L. Watts, MD, is the vice chair and director of Urologic Oncology Services in the Department of Urology at Montefiore Health System and Montefiore Einstein Comprehensive Cancer Center, as well as an associate professor of urology at Albert Einstein College of Medicine in the Bronx, New York.
Articles by Kara L. Watts, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia
2
FDA Approves Rusfertide for Polycythemia Vera
3
DESTINY-Breast05 Safety Analysis Clarifies ILD and Radiation Risks With T-DXd in HER2+ Breast Cancer
4
DAWN-303 Trial Set to Advance INCB161734 in First-Line KRAS G12D–Mutated Metastatic Pancreatic Cancer
5